# Study of the Safety and Efficacy of Prenofitol Tablets

Study · id `cardio:ct-nct07908433` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07908433](<https://clinicaltrials.gov/study/NCT07908433>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07908433

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 160 participants.

## Technical summary

Registry record NCT07908433. Randomized; quadruple masking; primary purpose prevention. Start 2026-11-02 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT07908433, source copy `cardio:ctgov-nct07908433-2026-11-02`, retrieved 2026-11-18)
- Planned start: 2026-11-02 (anticipated) (ClinicalTrials.gov record NCT07908433, source copy `cardio:ctgov-nct07908433-2026-11-02`, retrieved 2026-11-18)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07908433, source copy `cardio:ctgov-nct07908433-2026-11-02`, retrieved 2026-11-18)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07908433, source copy `cardio:ctgov-nct07908433-2026-11-02`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07908433-2026-11-02`, retrieved 2026-11-18)

## The registry's words

- Brief title: Study of the Safety and Efficacy of Prenofitol Tablets
- Condition: Dyslipidemia
- Intervention (Drug): 1 tablet of Prenofitol
- Intervention (Drug): 2 tablets of Prenofitol
- Intervention (Drug): 1 tablet of placebo
- Intervention (Drug): 2 tablets of placebo
- Lead sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)

## Provenance

Content hash: 10ec68a3a652042a68e77b0edb3f647dd583f11fb22d43b50e824ff265ca712d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
